Effects of several quinones on insulin aggregation

Topic: Gut, metabolism and diet

Protein misfolding and aggregation are associated with more than twenty diseases, such as neurodegenerative diseases and metabolic diseases. The amyloid oligomers and fibrils may induce cell membrane disruption and lead to cell apoptosis. A great number of studies have focused on discovery of amyloid inhibitors which may prevent or treat amyloidosis diseases. Polyphenols have been extensively studied as a class of amyloid inhibitors, with several polyphenols under clinical trials as anti-neurodegenerative drugs. As oxidative intermediates of natural polyphenols, quinones widely exist in medicinal plants or food. In this study, we used insulin as an amyloid model to test the anti-amyloid effects of four simple quinones and four natural anthraquinone derivatives from rhubarb, a traditional herbal medicine used for treating Alzheimer's disease. Our results demonstrated that all eight quinones show inhibitory effects to different extent on insulin oligomerization, especially for 1,4-benzoquinone and 1,4-naphthoquinone. Significantly attenuated oligomerization, reduced amount of amyloid fibrils and reduced hemolysis levels were found after quinones treatments, indicating quinones may inhibit insulin from forming toxic oligomeric species. The results suggest a potential action of native anthraquinone derivatives in preventing protein misfolding diseases, the quinone skeleton may thus be further explored for designing effective anti-amyloidosis compounds.

Key findings

• Protein misfolding and aggregation are associated with more than twenty diseases, such as neurodegenerative diseases and metabolic diseases.
• Our results demonstrated that all eight quinones show inhibitory effects to different extent on insulin oligomerization, especially for 1,4-benzoquinone and 1,4-naphthoquinone.
• Significantly attenuated oligomerization, reduced amount of amyloid fibrils and reduced hemolysis levels were found after quinones treatments, indicating quinones may inhibit insulin from forming toxic oligomeric species.
• The results suggest a potential action of native anthraquinone derivatives in preventing protein misfolding diseases, the quinone skeleton may thus be further explored for designing effective anti-amyloidosis compounds.

New to this subject? Start with our plain-English guide: Treatments →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1038/srep05648
• PubMed: 25008537
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{gong2014-25008537,
  author  = {Gong, H. and He, Z. and Peng, A. and Zhang, X. and Cheng, B. and Sun, Y. and Zheng, L. and Huang, K.},
  title   = {{Effects of several quinones on insulin aggregation}},
  journal = {Scientific reports},
  year    = {2014},
  doi     = {10.1038/srep05648},
  pmid    = {25008537},
  url     = {https://doi.org/10.1038/srep05648}
}

Related studies in Treatments

• Anti-Amyloid Aggregation Effects of Gobaishi (Galla chinensis) and Its Active Constituents Molecules · 2025-06-24 · usefulness score 39/100
• Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA neurology · 2020-09-01 · usefulness score 77/100
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial Archives of neurology · 2011-09-12 · usefulness score 74/100
• Effect of fresh pomegranate juice on the level of melatonin, insulin, and fasting serum glucose in healthy individuals and people with impaired fasting glucose Food science & nutrition · 2019-12-17 · usefulness score 42/100
• Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials JAMA Neurology · 2026-05-18 · usefulness score 58/100
• Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease Nature communications · 2022-11-04 · usefulness score 57/100

Also tagged “curcumin”

117 studies in the library carry the topic tag “curcumin”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 117 tagged studies.

• Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease Molecules (Basel, Switzerland) · 2017-02-13 · usefulness score 41/100 · Disease mechanisms
• Medical Use of Cannabinoids Drugs · 2018-11-01 · usefulness score 38/100 · Brain scans and imaging
• Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions Biotechnology advances · 2016-12-30 · usefulness score 38/100 · Drug development

Similar studies

• Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism 2006 · Risk factors
• (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway 2009 · Treatments
• Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies 2019 · Drug development
• Multi-Targeting Phytochemicals for Alzheimer's Disease 2025 · Treatments
• Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry 2016 · Treatments
• Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo 2005 · Vascular contributions

More on Treatments

• A review that covers this ground Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration Angewandte Chemie (International ed. in English) · 2019-11-28 · usefulness score 41/100
• Newest in this subject Opposing Regulation of Tau Condensation by Phosphorylation Levels and Molecular Chaperone Interactions bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Natural Sesquiterpenoids from Laggera pterodonta as bioactive Acetylcholinesterase Inhibitors: Insights from DFT, Molecular Docking, and ADMET Profiling Research Square · 2026-10-20 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Treatments →